Preventing perinatal group B streptococcal infection: The jury is still out

Medical Journal of Australia

Volumn 178, Issue 5, 2003, Pages 199-200

  Gilbert, Gwendolyn L ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIAL COLONIZATION; CLINICAL PROTOCOL; DISEASE CONTROL; DRUG COST; EDITORIAL; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MEDICAL DECISION MAKING; NEWBORN SEPSIS; NONHUMAN; PATIENT COMPLIANCE; PERINATAL INFECTION; PRACTICE GUIDELINE; PRENATAL SCREENING; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0037416233     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05160.x     Document Type: Editorial

References (14)

1. Gilbert GL, Garland SM. Perinatal group B streptococcal infections. Med J Aust 1983; 1: 566-571.
2. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983; 148: 810-816.
3. Jeffery HE, Moses LM. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 1998; 101: E2.
4. Gilbert GL, Hewitt MC, Turner CM, Leeder SR. Epidemiology and predictive values of risk factors for neonatal group B streptococcal sepsis. Aust N Z J Obstet Gynaecol 2002; 42: 494-503.
5. Isaacs D, Royle JA. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatr Infect Dis J 1999; 18: 524-528.
6. Prevention of perinatal group B streptococcal disease: A public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996; 45 (RR-7): 1-24.
7. Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: Case-control study. BMJ 2002; 325: 308-312.
8. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
9. Smaill F. Intrapartum antibiotics for Group B streptococcal colonisation. Cochrane Database Syst Rev 2002; 2: CD000115.
10. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-247.
11. Towers C.V, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: The next 4 years. Am J Obstet Gynecol 2002; 187: 495-500.
12. Prevention of perinatal group B streptococcaldiseases. Prevention of perinatal group B streptococcal diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51 (RR-11): 1-22.
13. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233-239.
14. Gilbert GL, Isaacs D, Burgess MA, et al. Prevention of neonatal group B streptococcal sepsis: Is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol 1995; 35: 120-126.